Atherogenic lipid profile in children with subclinical hypothyroidism;Perfil lipídico aterogénico en niños con hipotiroidismo subclínico

Anales de Pediatria

Volumn 62, Issue 2, 2005, Pages 128-134

  Paoli Valeri, M ^a,c   Guzman M ^a   Jimenez Lopez V ^b   Arias Ferreira, A ^b   Briceno Fernandez M ^b   Arata Bellabarba, G ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b Ctro de Estud/Prev Retarde Mental   (Venezuela)

^c Urb La Mara   (Venezuela)

Author keywords

Children; Lipids; Lipoproteine; Subclinical hypothyroidism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ANTIBODY DETECTION; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EVALUATION; EXTRACTION; FEMALE; FREQUENCY MODULATION; HUMAN; HYPOTHYROIDISM; LIPID ANALYSIS; MALE; STATISTICAL SIGNIFICANCE;

EID: 16244380468     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13071309     Document Type: Article

References (33)

1. Fenzi G, Salvatore D, De Riu S, Marzano L, Vitale M. Subclinical hypothyroidism. En; Pinchera A, Mann K, Hostalek U, editors. The thyroid and age. Stuttgart: RK. Schattauer, 1998; p. 305-14.
2. Paoli-Valeri M. Mamán-Alvarado D, Jiménez-López V. Arias-Ferreira A, Blanchi G. Arata-Bellabarba G. Frecuencia de hipotiroidismo subclínico en niños sanos y con alteraciones neurológicas en el estado Mérida, Venezuela. Invest Clin 2003;44: 209-18.
3. Loviselli A, Velluzzi F, Mossa P, Cambosu M, Secci G, Atzeni F, et al. The Sardinian autoimmunity study: Three studies on circulation antithyroid antibodies in Sardinian Schoolchildren: Relationship to goiter prevalence and thyroid function. Thyroid 2001;11:849-57.
4. Hamburger J, Meier D, Szpunar W. Factitious elevation of thyrotropin in euthyroid patients [carta]. N Engl J Med 1985;313: 267.
5. Vanderpump M, Tunbridge W, French J, Appleton D, Bates D, Clark F. The incidence of thyroid disorders in the community: a twenty year follow-up of the Wickham survey. Clin Endocrinol 1995;43:55-68.
6. Sklar C, Oazi R, David R. Juvenil autoimmune thyroiditis. AJDC 1986;140:877-80.
7. Canaris G, Manowitz N, Mayor G, Rigway Ch. The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 2000;160: 526-34.
8. Paoli M, Bellabarba G, Velázquez E, Mendoza S, Molina C, Wang P. Sex steroids, lipids and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy. Chim Acta 1998;275:81-91.
9. Davies H. Atherogenesis and the coronary arteries in childhood. Int J Cardiol 1990;28:283-92.
10. Haust M. The genesis of atherosclerosis in pediatric age-group. Pediatr Pathol 1990;10:253-71.
11. Strong J, Malcom G, McMahan C. Prevalence and extent of atherosclerosis in adolescents and young adults. JAMA 1999; 281:727-35.
12. McGill H Jr, McMahan C, Tracy R, Oalmann M, Comhill J, Herderick E. et al. Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vase Biol 1998;18:1108-18.
13. Friedewald W, Levy R, Frederickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparate ultracentrifuge. Clin Chem 1972; 18:499-515.
14. Ishikawa T, Brazier J, Steiner P, Steward L, Gartside B, Glueck C. A study of the heparin-manganese chloride methods for determination of plasma alpha-lipoprotein cholesterol concentration. Lipids 1976;11:628-39.
15. National Institutes of Health. Report of The Expert Panel on Blood Cholesterol Levels in Children and Adolescents. U.S. Department of Health and Human Services. NIH Publication n.° 91-2732, Sept. 1991.
16. Moore D. Natural course of subclinical hypothyroidism in childhood and adolescence. Arch Pediatr Adolesc Med 1996; 150:293-7.
17. Garber A, Browner W, Hulley S. Cholesterol screening in asymptomatic adult. Ann Intern Med 1996;124:518-31.
18. García B, García C, Jiménez C, Nebreda P, Calvo C, García A, et al. Valores de tirotropina, triyodotironina libre y tiroxina libre en niños y adolescentes en la Comunidad Autonoma de Madrid mediante quimioluminiscencia. An Pediatr (Bare) 2003; 58:222-7.
19. Cooper D, Halpern R, Wood L, Levin A, Ridgway E. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 1984;101:18-24.
20. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with subclinical hypothyroidism. Clin Endocrinol (Oxf) 1988;29:63-75.
21. Althaus B, Staub J, Riff A, Oberhansli A. Stahelin B. LDL/HDL Changes in subclinical hypothyroidism possible risk factors for coronary heart disease. Clin Endocrinol 1988;28:157-63.
22. Caron P, Calazel C, Parra H. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol 1990;33:519.
23. Danese M, Ladenson P, Meinert C, Powwe N. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature. J Clin Endocrinol Metab 2000;85:2993-3001.
24. Duntas L. Thyroid disease and lipids. Thyroid 2002;12:287-93.
25. Tall A. Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255-74.
26. Tan K, Shiu S, Kung A. Plasma cholesteryl ester transfer protein activity in hyper and hypothyroidism. J Clin Endocrinol Metab 1998;83:140-3.
27. Huesca-Gómez C, Franco M, Luc G, Montano L, Masso F, Posadas-Romero C, et al. Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat. Metabolism 2002;51: 443-50.
28. Lithell H, Boberg J, Hellsing K, Lyunhall S, Lundquist G, Vessby B, et al. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein lipase activity in overt and subclinical hypothyroidis, The effect of substitution therapy. Eur J Clin Invest 1981;11:1-10.
29. Staub J, Althaus B, Engler H, Ryff A, Trabucco P, Marquardt K, et al. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92:631-42.
30. Hak A, Pols H, Visser T, Drexhage H, Hofman A, Witteman C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women. The Rotterdam Study. Ann Intern Med 2000;132:270-8.
31. Tieche M, Lupu G, Gutzwiller F, Grob P, Buergi H. Borderline low thyroid function and thyroid autoinmunity. Risk factors for coronary heart disease? B Heart J 1981;46:202-6.
32. Dean J, Fowler P. Exaggerated responsiveness to thyrotrophin releasing hormone: A risk factor in women with coronary artery disease. BMJ 1985;290:1555-61.
33. Perk M, O'Neill B. The effect of thyroid hormone therapy on angiographie coronary artery disease progression. Can J Cardiol 1997;13:273-6.